CPT code 86022: Platelet antibodies, antibody identification2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Identifies platelet-directed antibodies in testing for immune-mediated platelet destruction, platelet transfusion refractoriness, or other suspected platelet antibody conditions.
Medicare pays $18.37 for 86022 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$18.37
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 86022 covers
This laboratory test identifies antibodies directed against platelets. It may be ordered when evaluating suspected immune-mediated thrombocytopenia, platelet transfusion refractoriness, or other conditions in which platelet antibodies could explain a low platelet count or poor response to transfusion. Testing is generally performed by a clinical laboratory or immunohematology reference laboratory on a patient specimen; the result supports the treating clinician’s assessment alongside the platelet count, clinical history, and transfusion findings.
Report 86022 for platelet antibody identification, rather than leukocyte antibody identification or a platelet count. Medicare pays the test through the CLFS, with one national amount applicable across localities and settings and no office-versus-facility adjustment. The 2026 national CLFS amount is $18.37, unchanged from 2020. The code is paid only from the CLFS; it has no separate physician fee schedule payment.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 86022
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 86022. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 86022 with status X (excluded by statute), so the test itself is paid only from the CLFS.
86022 on the lab fee schedule since 2020
86022 · CLFS 2026 Q4 (current)
$18.37
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
86022 compared with similar tests
- 86021WBC antibodiesAntibody identification$15.05
- Use 86022 for platelet-directed antibodies and 86021 for leukocyte-directed antibodies.
- 86023Platelet Ig assayPlatelet-associated immunoglobulin$12.46
- 86022 identifies platelet antibodies; 86023 describes an immunoglobulin assay rather than platelet antibody identification.
- 85049Platelet countAutomated method$4.48
- 85049 measures the platelet count. It does not identify antibodies against platelets.
86022 billing questions
When should 86022 be chosen over 86021?
Use 86022 when the laboratory identifies antibodies directed against platelets. Code 86021 is for leukocyte antibody identification.
Is 86022 a platelet count?
No. It identifies platelet-directed antibodies; a platelet count is a separate laboratory service, such as 85049.
Does Medicare pay 86022 through the CLFS?
Yes. Medicare pays it at one national CLFS amount, without a locality or office-versus-facility adjustment.
Is there a separate physician interpretation payment?
No separate physician fee schedule payment is listed for 86022; Medicare pays the test only through the CLFS.
How should units be reported?
The unit is the platelet antibody identification service, not each antibody specificity.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 86022 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist